Skip to main content
SpringerLink
Log in

Nanotechnology for Cancer Vaccine Delivery

  • Chapter
Nanotechnology in Drug Delivery

Part of the book series: Biotechnology: Pharmaceutical Aspects ((PHARMASP,volume X))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akira, S., Takeda, K., & Kaisho, T. (2001). Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol, 2(8), 675–680.

    CAS  PubMed  Google Scholar 

  • Alas, S., & Bonavida, B. (2003). Inhibition of constitutive stat3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis. Clin Cancer Res, 9(1), 316–326.

    CAS  PubMed  Google Scholar 

  • Albert, M. L., Sauter, B., & Bhardwaj, N. (1998). Dendritic cells acquire antigen from apoptotic cells and induce class i-restricted ctls. Nature, 392(6671), 86–89.

    CAS  PubMed  Google Scholar 

  • Albertsson, P. A., Basse, P. H., Hokland, M., Goldfarb, R. H., Nagelkerke, J. F., Nannmark, U., et al. (2003). Nk cells and the tumour microenvironment: Implications for nk-cell function and anti-tumour activity. Trends Immunol, 24(11), 603–609.

    CAS  PubMed  Google Scholar 

  • Banchereau, J., & Palucka, A. K. (2005). Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol, 5(4), 296–306.

    CAS  PubMed  Google Scholar 

  • Banchereau, J., & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 392(6673), 245–252.

    CAS  PubMed  Google Scholar 

  • Bernards, R., Destree, A., McKenzie, S., Gordon, E., Weinberg, R. A., & Panicali, D. (1987). Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector. Proc Natl Acad Sci USA, 84(19), 6854–6858.

    Google Scholar 

  • Beutler, B. (2004). Inferences, questions and possibilities in toll-like receptor signalling. Nature, 430(6996), 257–263.

    CAS  PubMed  Google Scholar 

  • Blaskovich, M. A., Sun, J., Cantor, A., Turkson, J., Jove, R., & Sebti, S. M. (2003). Discovery of jsi-124 (cucurbitacin i), a selective janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res, 63, 1270–1279.

    CAS  PubMed  Google Scholar 

  • Borst, J., Hendriks, J., & Xiao, Y. (2005). Cd27 and cd70 in t cell and b cell activation. Curr Opin Immunol, 17(3), 275–281.

    CAS  PubMed  Google Scholar 

  • Bousso, P., & Robey, E. (2003). Dynamics of cd8+ t cell priming by dendritic cells in intact lymph nodes. Nat Immunol, 4(6), 579–585.

    CAS  PubMed  Google Scholar 

  • Brandacher, G., Winkler, C., Schroecksnadel, K., Margreiter, R., & Fuchs, D. (2006). Antitumoral activity of interferon-gamma involved in impaired immune function in cancer patients. Curr Drug Metab, 7(6), 599–612.

    CAS  PubMed  Google Scholar 

  • Brigl, M., & Brenner, M. B. (2004). Cd1: Antigen presentation and t cell function. Annu Rev Immunol, 22, 817–890.

    CAS  PubMed  Google Scholar 

  • Cady, S. G., & Sono, M. (1991). 1-methyl-dl-tryptophan, beta-(3-benzofuranyl)-dl-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-dl-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch Biochem Biophys, 291(2), 326–333.

    CAS  PubMed  Google Scholar 

  • Casadevall, A. (1999). Passive antibody therapies: Progress and continuing challenges. Clin Immunol, 93(1), 5–15.

    CAS  PubMed  Google Scholar 

  • Cella, M., Engering, A., Pinet, V., Pieters, J., & Lanzavecchia, A. (1997). Inflammatory stimuli induce accumulation of mhc class ii complexes on dendritic cells. Nature, 388(6644), 782–787.

    CAS  PubMed  Google Scholar 

  • Chang, D. H., Osman, K., Connolly, J., Kukreja, A., Krasovsky, J., Pack, M., et al. (2005). Sustained expansion of nkt cells and antigen-specific t cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients. J Exp Med, 201(9), 1503–1517.

    CAS  PubMed  Google Scholar 

  • Chaux, P., Moutet, M., Faivre, J., Martin, F., & Martin, M. (1996). Inflammatory cells infiltrating human colorectal carcinomas express hla class ii but not b7-1 and b7-2 costimulatory molecules of the t-cell activation. Lab Invest, 74(5), 975–983.

    CAS  PubMed  Google Scholar 

  • Cheng, F., Wang, H. W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., et al. (2003). A critical role for stat3 signaling in immune tolerance. Immunity, 19(3), 425–436.

    CAS  PubMed  Google Scholar 

  • Chiu, Y. L., Ali, A., Chu, C. Y., Cao, H., & Rana, T. M. (2004). Visualizing a correlation between sirna localization, cellular uptake, and rnai in living cells. Chem Biol, 11(8), 1165–1175.

    CAS  PubMed  Google Scholar 

  • Cooper, M. A., Fehniger, T. A., Fuchs, A., Colonna, M., & Caligiuri, M. A. (2004). Nk cell and dc interactions. Trends Immunol, 25(1), 47–52.

    CAS  PubMed  Google Scholar 

  • Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., et al. (2003). Liposomal delivery of antigen to human dendritic cells. Vaccine, 21(9–10), 883–890.

    CAS  PubMed  Google Scholar 

  • Cumberbatch, M., & Kimber, I. (1995). Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology, 84(1), 31–35.

    CAS  PubMed  Google Scholar 

  • Datta, S. K., Redecke, V., Prilliman, K. R., Takabayashi, K., Corr, M., Tallant, T., et al. (2003). A subset of toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J Immunol, 170(8), 4102–4110.

    CAS  PubMed  Google Scholar 

  • De Vries, I. J., Krooshoop, D. J., Scharenborg, N. M., Lesterhuis, W. J., Diepstra, J. H., Van Muijen, G. N., et al. (2003). Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res, 63(1), 12–17.

    PubMed  Google Scholar 

  • Degli-Esposti, M. A., & Smyth, M. J. (2005). Close encounters of different kinds: Dendritic cells and nk cells take centre stage. Nat Rev Immunol, 5(2), 112–124.

    CAS  PubMed  Google Scholar 

  • Dermime, S., Armstrong, A., Hawkins, R. E., & Stern, P. L. (2002). Cancer vaccines and immunotherapy. Br Med Bull, 62, 149–162.

    PubMed  Google Scholar 

  • Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., & Bhardwaj, N. (2001). Antigen-specific inhibition of effector t cell function in humans after injection of immature dendritic cells. J Exp Med, 193(2), 233–238.

    CAS  PubMed  Google Scholar 

  • Diehl, L., den Boer, A. T., Schoenberger, S. P., van der Voort, E. I., Schumacher, T. N., Melief, C. J., et al. (1999). Cd40 activation in vivo overcomes peptide-induced peripheral cytotoxic t-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med, 5(7), 774–779.

    CAS  PubMed  Google Scholar 

  • Diwan, M., Elamanchili, P., Cao, M., & Samuel, J. (2004). Dose sparing of cpg oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery. Curr Drug Deliv, 1(4), 405–412.

    CAS  PubMed  Google Scholar 

  • Diwan, M., Elamanchili, P., Lane, H., Gainer, A., & Samuel, J. (2003). Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary t cell responses. J Drug Target, 11(8–10), 495–507.

    CAS  PubMed  Google Scholar 

  • Elamanchili, P., Lutsiak, C., Hamdy, S., Diwan, M., & Samuel, J. (2007). Pathogen-mimicking' nanoparticles for vaccine delivery to dendritic cells. J Immunother, 30(4), 378–395.

    Google Scholar 

  • Elamanchili, P., Diwan, M., Cao, M., & Samuel, J. (2004). Characterization of poly(d,l-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine, 22(19), 2406–2412.

    CAS  PubMed  Google Scholar 

  • Enk, A. H., Jonuleit, H., Saloga, J., & Knop, J. (1997). Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer, 73(3), 309–316.

    CAS  PubMed  Google Scholar 

  • Fehervari, Z., & Sakaguchi, S. (2004). Control of foxp3+ cd25+cd4+ regulatory cell activation and function by dendritic cells. Int Immunol, 16(12), 1769–1780.

    CAS  PubMed  Google Scholar 

  • Foged, C., Sundblad, A., & Hovgaard, L. (2002). Targeting vaccines to dendritic cells. Pharm Res, 19(3), 229–238.

    CAS  PubMed  Google Scholar 

  • Friberg, M., Jennings, R., Alsarraj, M., Dessureault, S., Cantor, A., Extermann, M., et al. (2002). Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of t cell-mediated rejection. Int J Cancer, 101(2), 151–155.

    CAS  PubMed  Google Scholar 

  • Fujii, S., Shimizu, K., Smith, C., Bonifaz, L., & Steinman, R. M. (2003). Activation of natural killer t cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined cd4 and cd8 t cell immunity to a coadministered protein. J Exp Med, 198(2), 267–279.

    CAS  PubMed  Google Scholar 

  • Gabrilovich, D. I., Corak, J., Ciernik, I. F., Kavanaugh, D., & Carbone, D. P. (1997). Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res, 3(3), 483–490.

    CAS  PubMed  Google Scholar 

  • Gao, L., Zhang, L., Hu, J., Li, F., Shao, Y., Zhao, D., et al. (2005a). Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering rnas suppresses growth of human prostate tumor in vivo. Clin Cancer Res, 11(17), 6333–6341.

    CAS  Google Scholar 

  • Gao, L. F., Xu, D. Q., Wen, L. J., Zhang, X. Y., Shao, Y. T., & Zhao, X. J. (2005b). Inhibition of stat3 expression by sirna suppresses growth and induces apoptosis in laryngeal cancer cells. Acta Pharmacol Sin, 26(3), 377–383.

    CAS  Google Scholar 

  • Gao, L. F., Wen, L. J., Yu, H., Zhang, L., Meng, Y., Shao, Y. T., et al. (2006). Knockdown of stat3 expression using rnai inhibits growth of laryngeal tumors in vivo. Acta Pharmacol Sin, 27(3), 347–352.

    CAS  PubMed  Google Scholar 

  • Garg, S., Oran, A., Wajchman, J., Sasaki, S., Maris, C. H., Kapp, J. A., et al. (2003). Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat Immunol, 4(9), 907–912.

    CAS  PubMed  Google Scholar 

  • Gaspari, P., Banerjee, T., Malachowski, W. P., Muller, A. J., Prendergast, G. C., DuHadaway, J., et al. (2006). Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors. J Med Chem, 49(2), 684–692.

    CAS  PubMed  Google Scholar 

  • Geng, D., Joshi, S. K., Podolsky, R., & She, J. X. (2007). Gcsf receptor regulates antigen uptake and expression of cytokines and costimulatory molecules in dendritic cells. Mol Immunol, 44(4), 521–529.

    CAS  PubMed  Google Scholar 

  • Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G., & Trinchieri, G. (2002). Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med, 195(3), 327–333.

    CAS  PubMed  Google Scholar 

  • Godfrey, D. I., & Kronenberg, M. (2004). Going both ways: Immune regulation via cd1d-dependent nkt cells. J Clin Invest, 114(10), 1379–1388.

    CAS  PubMed  Google Scholar 

  • Gong, J., Chen, D., Kashiwaba, M., & Kufe, D. (1997). Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med, 3(5), 558–561.

    CAS  PubMed  Google Scholar 

  • Hamdy, S., Elamanchili, P., Alshamsan, A., Molavi, O., Satou, T., & Samuel, J. (2007). Enhanced antigen-specific primary cd4+ and cd8+ responses by co-delivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid a in poly(d,l-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A, 81(3), 652–662.

    Google Scholar 

  • Heikenwalder, M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, S., et al. (2004). Lymphoid follicle destruction and immunosuppression after repeated cpg oligodeoxynucleotide administration. Nat Med, 10(2), 187–192.

    CAS  PubMed  Google Scholar 

  • Heit, A., Huster, K. M., Schmitz, F., Schiemann, M., Busch, D. H., & Wagner, H. (2004). Cpg-DNA aided cross-priming by cross-presenting b cells. J Immunol, 172(3), 1501–1507.

    CAS  PubMed  Google Scholar 

  • Hertz, C. J., Kiertscher, S. M., Godowski, P. J., Bouis, D. A., Norgard, M. V., Roth, M. D., et al. (2001). Microbial lipopeptides stimulate dendritic cell maturation via toll-like receptor 2. J Immunol, 166(4), 2444–2450.

    CAS  PubMed  Google Scholar 

  • Hill, J. A., Ichim, T. E., Kusznieruk, K. P., Li, M., Huang, X., Yan, X., et al. (2003). Immune modulation by silencing il-12 production in dendritic cells using small interfering rna. J Immunol, 171(2), 691–696.

    CAS  PubMed  Google Scholar 

  • Hirao, M., Onai, N., Hiroishi, K., Watkins, S. C., Matsushima, K., Robbins, P. D., et al. (2000). Cc chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: Critical role in migration from the tumor site to draining lymph nodes. Cancer Res, 60(8), 2209–2217.

    CAS  PubMed  Google Scholar 

  • Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. O., et al. (2006). Rna interference in vitro and in vivo using a novel chitosan/sirna nanoparticle system. Mol Ther, 14(4), 476–484.

    CAS  PubMed  Google Scholar 

  • Hwu, P., Du, M. X., Lapointe, R., Do, M., Taylor, M. W., & Young, H. A. (2000). Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of t cell proliferation. J Immunol, 164(7), 3596–3599.

    CAS  PubMed  Google Scholar 

  • Itaka, K., Kanayama, N., Nishiyama, N., Jang, W. D., Yamasaki, Y., Nakamura, K., et al. (2004). Supramolecular nanocarrier of sirna from peg-based block catiomer carrying diamine side chain with distinctive pka directed to enhance intracellular gene silencing. J Am Chem Soc, 126(42), 13612–13613.

    CAS  PubMed  Google Scholar 

  • Iwasaki, A., & Medzhitov, R. (2004). Toll-like receptor control of the adaptive immune responses. Nat Immunol, 5(10), 987–995.

    CAS  PubMed  Google Scholar 

  • Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., & Enk, A. H. (2000). Induction of interleukin 10-producing, nonproliferating cd4(+) t cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med, 192(9), 1213–1222.

    CAS  PubMed  Google Scholar 

  • Kakizawa, Y., Furukawa, S., & Kataoka, K. (2004). Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and sirna delivery. J Control Release, 97(2), 345–356.

    CAS  PubMed  Google Scholar 

  • Kamath, A. T., Sheasby, C. E., & Tough, D. F. (2005). Dendritic cells and nk cells stimulate bystander t cell activation in response to tlr agonists through secretion of ifn-alpha beta and ifn-gamma. J Immunol, 174(2), 767–776.

    CAS  PubMed  Google Scholar 

  • Kaufman, H. L., & Disis, M. L. (2004). Immune system versus tumor: Shifting the balance in favor of dcs and effective immunity. J Clin Invest, 113(5), 664–667.

    CAS  PubMed  Google Scholar 

  • Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., et al. (1997). Cd1d-restricted and tcr-mediated activation of valpha14 nkt cells by glycosylceramides. Science, 278(5343), 1626–1629.

    CAS  PubMed  Google Scholar 

  • Khaled, A., Guo, S., Li, F., & Guo, P. (2005). Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using rna nanotechnology. Nano Lett, 5(9), 1797–1808.

    CAS  PubMed  Google Scholar 

  • Khan, A., Benboubetra, M., Sayyed, P. Z., Ng, K. W., Fox, S., Beck, G., et al. (2004). Sustained polymeric delivery of gene silencing antisense odns, sirna, dnazymes and ribozymes: In vitro and in vivo studies. J Drug Target, 12(6), 393–404.

    CAS  PubMed  Google Scholar 

  • Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S., Ohta, A., Ohmi, Y., et al. (1999). The natural killer t (nkt) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (il)-12 production by dendritic cells and il-12 receptor expression on nkt cells. J Exp Med, 189(7), 1121–1128.

    CAS  PubMed  Google Scholar 

  • Konnikova, L., Kotecki, M., Kruger, M. M., & Cochran, B. H. (2003). Knockdown of stat3 expression by rnai induces apoptosis in astrocytoma cells. BMC Cancer, 3, 23.

    PubMed  Google Scholar 

  • Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., et al. (2005). Inhibiting stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med, 11(12), 1314–1321.

    CAS  PubMed  Google Scholar 

  • Kowalczyk, D. W., Wysocki, P. J., & Mackiewicz, A. (2003). Cancer immunotherapy using cells modified with cytokine genes. Acta Biochim Pol, 50(3), 613–624.

    CAS  PubMed  Google Scholar 

  • Kubo, T., Hatton, R. D., Oliver, J., Liu, X., Elson, C. O., & Weaver, C. T. (2004). Regulatory t cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by tlr-activated dendritic cells. J Immunol, 173(12), 7249–7258.

    CAS  PubMed  Google Scholar 

  • Kunisawa, J., Masuda, T., Katayama, K., Yoshikawa, T., Tsutsumi, Y., Akashi, M., et al. (2005). Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release. J Control Release, 105(3), 344–353.

    CAS  PubMed  Google Scholar 

  • Laderach, D., Compagno, D., Danos, O., Vainchenker, W., & Galy, A. (2003). Rna interference shows critical requirement for nf-kappa b p50 in the production of il-12 by human dendritic cells. J Immunol, 171(4), 1750–1757.

    CAS  PubMed  Google Scholar 

  • Lathe, R., Kieny, M. P., Gerlinger, P., Clertant, P., Guizani, I., Cuzin, F., et al. (1987). Tumour prevention and rejection with recombinant vaccinia. Nature, 326(6116), 878–880.

    CAS  PubMed  Google Scholar 

  • Lee, J. R., Dalton, R. R., Messina, J. L., Sharma, M. D., Smith, D. M., Burgess, R. E., et al. (2003). Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. Lab Invest, 83(10), 1457–1466.

    CAS  PubMed  Google Scholar 

  • Lee, S. O., Lou, W., Qureshi, K. M., Mehraein-Ghomi, F., Trump, D. L., & Gao, A. C. (2004). Rna interference targeting stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate, 60(4), 303–309.

    CAS  PubMed  Google Scholar 

  • Liu, G., Ng, H., Akasaki, Y., Yuan, X., Ehtesham, M., Yin, D., et al. (2004). Small interference rna modulation of il-10 in human monocyte-derived dendritic cells enhances the th1 response. Eur J Immunol, 34(6), 1680–1687.

    CAS  PubMed  Google Scholar 

  • Lutsiak, C. M., Sosnowski, D. L., Wishart, D. S., Kwon, G. S., & Samuel, J. (1998). Use of a liposome antigen delivery system to alter immune responses in vivo. J Pharm Sci, 87(11), 1428–1432.

    CAS  PubMed  Google Scholar 

  • Lutsiak, M. E., Kwon, G. S., & Samuel, J. (2006). Biodegradable nanoparticle delivery of a th2-biased peptide for induction of th1 immune responses. J Pharm Pharmacol, 58(6), 739–747.

    CAS  PubMed  Google Scholar 

  • Mack, C. A., Song, W. R., Carpenter, H., Wickham, T. J., Kovesdi, I., Harvey, B. G., et al. (1997). Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum Gene Ther, 8(1), 99–109.

    CAS  PubMed  Google Scholar 

  • Means, T. K., Hayashi, F., Smith, K. D., Aderem, A., & Luster, A. D. (2003). The toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol, 170(10), 5165–5175.

    CAS  PubMed  Google Scholar 

  • Melief, C. J., Van Der Burg, S. H., Toes, R. E., Ossendorp, F., & Offringa, R. (2002). Effective therapeutic anticancer vaccines based on precision guiding of cytolytic t lymphocytes. Immunol Rev, 188, 177–182.

    CAS  PubMed  Google Scholar 

  • Mercer, J. C., Ragin, M. J., & August, A. (2005). Natural killer t cells: Rapid responders controlling immunity and disease. Int J Biochem Cell Biol, 37(7), 1337–1343.

    CAS  PubMed  Google Scholar 

  • Mesa, C., & Fernandez, L. E. (2004). Challenges facing adjuvants for cancer immunotherapy. Immunol Cell Biol, 82(6), 644–650.

    CAS  PubMed  Google Scholar 

  • Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005). Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene bin1, potentiates cancer chemotherapy. Nat Med, 11(3), 312–319.

    CAS  PubMed  Google Scholar 

  • Muller, A. J., & Prendergast, G. C. (2005). Marrying immunotherapy with chemotherapy: Why say ido? Cancer Res, 65(18), 8065–8068.

    CAS  PubMed  Google Scholar 

  • Munn, D. H., & Mellor, A. L. (2004). Ido and tolerance to tumors. Trends Mol Med, 10(1), 15–18.

    CAS  PubMed  Google Scholar 

  • Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., et al. (2004). Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest, 114(2), 280–290.

    CAS  PubMed  Google Scholar 

  • Murthy N, C. J., Fausto N, Hoffman AS, Stayton PS. (2003). Bioinspired ph-responsive polymers for the intracellular delivery of biomolecular drugs. Bioconjug Chem, 14(2), 412–419.

    Google Scholar 

  • Neeson, P., & Paterson, Y. (2006). Effects of the tumor microenvironment on the efficacy of tumor immunotherapy. Immunol Invest, 35(3–4), 359–394.

    CAS  PubMed  Google Scholar 

  • Nefedova, Y., Cheng, P., Gilkes, D., Blaskovich, M., Beg, A. A., Sebti, S. M., et al. (2005a). Activation of dendritic cells via inhibition of jak2/stat3 signaling. J Immunol, 175(7), 4338–4346.

    CAS  Google Scholar 

  • Nefedova, Y., Nagaraj, S., Rosenbauer, A., Muro-Cacho, C., Sebti, S. M., & Gabrilovich, D. I. (2005b). Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res, 65(20), 9525–9535.

    CAS  Google Scholar 

  • Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., et al. (2004). Hyperactivation of stat3 is involved in abnormal differentiation of dendritic cells in cancer. J Immunol, 172(1), 464–474.

    CAS  PubMed  Google Scholar 

  • Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., et al. (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med, 4(3), 328–332.

    CAS  PubMed  Google Scholar 

  • Nestle, F. O., Banchereau, J., & Hart, D. (2001). Dendritic cells: On the move from bench to bedside. Nat Med, 7(7), 761–765.

    CAS  PubMed  Google Scholar 

  • Newman, K. D., Samuel, J., & Kwon, G. (1998). Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a t helper type 1 immune response. J Control Release, 54(1), 49–59.

    CAS  PubMed  Google Scholar 

  • Nicchitta, C. V. (2003). Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nat Rev Immunol, 3(5), 427–432.

    CAS  PubMed  Google Scholar 

  • Nishioka, Y., & Yoshino, H. (2001). Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev, 47(1), 55–64.

    CAS  PubMed  Google Scholar 

  • Niu, G., Heller, R., Catlett-Falcone, R., Coppola, D., Jaroszeski, M., Dalton, W., et al. (1999). Gene therapy with dominant-negative stat3 suppresses growth of the murine melanoma b16 tumor in vivo. Cancer Res, 59, 5059–5063.

    CAS  PubMed  Google Scholar 

  • O'Hagan D, S. M. (2003). Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines, 2, 269–283.

    PubMed  Google Scholar 

  • O'Hagan, D. T., & Valiante, N. M. (2003). Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov, 2(9), 727–735.

    PubMed  Google Scholar 

  • Orabona, C., Belladonna, M. L., Vacca, C., Bianchi, R., Fallarino, F., Volpi, C., et al. (2005). Cutting edge: Silencing suppressor of cytokine signaling 3 expression in dendritic cells turns cd28-ig from immune adjuvant to suppressant. J Immunol, 174(11), 6582–6586.

    CAS  PubMed  Google Scholar 

  • Oussoren, C., & Storm, G. (1997). Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: Iii. Influence of surface modification with poly(ethyleneglycol). Pharm Res, 14(10), 1479–1484.

    CAS  PubMed  Google Scholar 

  • Oussoren, C., & Storm, G. (2001). Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev, 50(1–2), 143–156.

    CAS  PubMed  Google Scholar 

  • Palmer, M., Parker, J., Modi, S., Butts, C., Smylie, M., Meikle, A., et al. (2001). Phase i study of the blp25 (muc1 peptide) liposomal vaccine for active specific immunotherapy in stage iiib/iv non-small-cell lung cancer. Clin Lung Cancer, 3(1), 49–57; discussion 58.

    CAS  PubMed  Google Scholar 

  • Pasare, C., & Medzhitov, R. (2003). Toll pathway-dependent blockade of cd4+cd25+ t cell-mediated suppression by dendritic cells. Science, 299(5609), 1033–1036.

    CAS  PubMed  Google Scholar 

  • Pinzon-Charry, A., Maxwell, T., & Lopez, J. A. (2005). Dendritic cell dysfunction in cancer: A mechanism for immunosuppression. Immunol Cell Biol, 83(5), 451–461.

    CAS  PubMed  Google Scholar 

  • Probst, H. C., Lagnel, J., Kollias, G., & van den Broek, M. (2003). Inducible transgenic mice reveal resting dendritic cells as potent inducers of cd8+ t cell tolerance. Immunity, 18(5), 713–720.

    CAS  PubMed  Google Scholar 

  • Razzaque, A., Dye, E., & Puri, R. K. (2000). Characterization of tumor vaccines during product development. Vaccine, 19(6), 644–647.

    CAS  PubMed  Google Scholar 

  • Reddy, S. T., Berk, D. A., Jain, R. K., & Swartz, M. A. (2006a). A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles. J Appl Physiol, 101(4), 1162–1169.

    CAS  Google Scholar 

  • Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A., & Swartz, M. A. (2006b). In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release, 112(1), 26–34.

    CAS  Google Scholar 

  • Reddy, S. T., Swartz, M. A., & Hubbell, J. A. (2006c). Targeting dendritic cells with biomaterials: Developing the next generation of vaccines. Trends Immunol, 27(12), 573–579.

    CAS  Google Scholar 

  • Rehor, A., Hubbell, J. A., & Tirelli, N. (2005). Oxidation-sensitive polymeric nanoparticles. Langmuir, 21(1), 411–417.

    CAS  PubMed  Google Scholar 

  • Richards Grayson, A. C., Doody, A. M., & Putnam, D. (2006). Biophysical and structural characterization of polyethylenimine-mediated sirna delivery in vitro. Pharm Res, 23(8), 1868–1876.

    Google Scholar 

  • Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004). Cancer immunotherapy: Moving beyond current vaccines. Nat Med, 10(9), 909–915.

    CAS  PubMed  Google Scholar 

  • Schroder, M., & Bowie, A. G. (2005). Tlr3 in antiviral immunity: Key player or bystander? Trends Immunol, 26(9), 462–468.

    PubMed  Google Scholar 

  • Schulz, O., Diebold, S. S., Chen, M., Naslund, T. I., Nolte, M. A., Alexopoulou, L., et al. (2005). Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature, 433(7028), 887–892.

    CAS  PubMed  Google Scholar 

  • Schuster, M., Nechansky, A., & Kircheis, R. (2006). Cancer immunotherapy. Biotechnol J, 1(2), 138–147.

    CAS  PubMed  Google Scholar 

  • Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., et al. (2006). Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology, 117(1), 78–88.

    CAS  PubMed  Google Scholar 

  • Smyth, M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H., & Godfrey, D. I. (2002). Nkt cells – conductors of tumor immunity? Curr Opin Immunol, 14(2), 165–171.

    CAS  PubMed  Google Scholar 

  • Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002). New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer, 2(11), 850–861.

    CAS  PubMed  Google Scholar 

  • Takeda, K., Kaisho, T., & Akira, S. (2003). Toll-like receptors. Annu Rev Immunol, 21, 335–376.

    CAS  PubMed  Google Scholar 

  • Tamura, Y., Peng, P., Liu, K., Daou, M., & Srivastava, P. K. (1997). Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science, 278(5335), 117–120.

    CAS  PubMed  Google Scholar 

  • Terness, P., Chuang, J. J., Bauer, T., Jiga, L., & Opelz, G. (2005). Regulation of human auto- and alloreactive t cells by indoleamine 2,3-dioxygenase (ido)-producing dendritic cells: Too much ado about ido? Blood, 105(6), 2480–2486.

    CAS  PubMed  Google Scholar 

  • Tsujitani, S., Furukawa, T., Tamada, R., Okamura, T., Yasumoto, K., & Sugimachi, K. (1987). Langerhans cells and prognosis in patients with gastric carcinoma. Cancer, 59(3), 501–505.

    CAS  PubMed  Google Scholar 

  • Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., et al. (2001). Phosphotyrosyl peptides block stat3-mediated dna binding activity, gene regulation, and cell transformation. J Biol Chem, 276(48), 45443–45455.

    CAS  PubMed  Google Scholar 

  • Tuting, T., Storkus, W. J., & Lotze, M. T. (1997). Gene-based strategies for the immunotherapy of cancer. J Mol Med, 75(7), 478–491.

    CAS  PubMed  Google Scholar 

  • Uyttenhove, C., Pilotte, L., Theate, I., Stroobant, V., Colau, D., Parmentier, N., et al. (2003). Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med, 9(10), 1269–1274.

    CAS  PubMed  Google Scholar 

  • van Duin, D., Medzhitov, R., & Shaw, A. C. (2006). Triggering tlr signaling in vaccination. Trends Immunol, 27(1), 49–55.

    PubMed  Google Scholar 

  • Walter, E., Dreher, D., Kok, M., Thiele, L., Kiama, S. G., Gehr, P., et al. (2001). Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of dna to human-derived macrophages and dendritic cells. J Control Release, 76(1–2), 149–168.

    CAS  PubMed  Google Scholar 

  • Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L., & Vivier, E. (2005). Natural-killer cells and dendritic cells: “l'union fait la force”. Blood, 106(7), 2252–2258.

    CAS  PubMed  Google Scholar 

  • Wan, T., Zhou, X., Chen, G., An, H., Chen, T., Zhang, W., et al. (2004). Novel heat shock protein hsp70l1 activates dendritic cells and acts as a th1 polarizing adjuvant. Blood, 103(5), 1747–1754.

    CAS  PubMed  Google Scholar 

  • Wang, D., Robinson, D. R., Kwon, G. S., & Samuel, J. (1999). Encapsulation of plasmid dna in biodegradable poly(d, l-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Control Release, 57(1), 9–18.

    CAS  PubMed  Google Scholar 

  • Warger, T., Osterloh, P., Rechtsteiner, G., Fassbender, M., Heib, V., Schmid, B., et al. (2006). Synergistic activation of dendritic cells by combined toll-like receptor ligation induces superior ctl responses in vivo. Blood, 108(2), 544–550.

    CAS  PubMed  Google Scholar 

  • Werth, S., Urban-Klein, B., Dai, L., Hobel, S., Grzelinski, M., Bakowsky, U., et al. (2006). A low molecular weight fraction of polyethylenimine (pei) displays increased transfection efficiency of dna and sirna in fresh or lyophilized complexes. J Control Release, 112(2), 257–270.

    CAS  PubMed  Google Scholar 

  • Xu, H., Chen, T., Wang, H. Q., Ji, M. J., Zhu, X., & Wu, W. X. (2006). Prolongation of rat intestinal allograft survival by administration of donor interleukin-12 p35-silenced bone marrow-derived dendritic cells. Transplant Proc, 38(5), 1561–1563.

    Google Scholar 

  • Yamaguchi, N., Hiraoka, S., Mukai, T., Takeuchi, N., Zhou, X. Y., Ono, S., et al. (2004). Induction of tumor regression by administration of b7-ig fusion proteins: Mediation by type 2 cd8+ t cells and dependence on il-4 production. J Immunol, 172(3), 1347–1354.

    CAS  PubMed  Google Scholar 

  • Yang, Y., Huang, C. T., Huang, X., & Pardoll, D. M. (2004). Persistent toll-like receptor signals are required for reversal of regulatory t cell-mediated cd8 tolerance. Nat Immunol, 5(5), 508–515.

    CAS  PubMed  Google Scholar 

  • Yee, C. (2005). Adoptive t cell therapy: Addressing challenges in cancer immunotherapy. J Transl Med, 3(1), 17.

    PubMed  Google Scholar 

  • Yuan, D., Koh, C. Y., & Wilder, J. A. (1994). Interactions between b lymphocytes and nk cells. Faseb J, 8(13), 1012–1018.

    CAS  PubMed  Google Scholar 

  • Yuan, D., Wilder, J., Dang, T., Bennett, M., & Kumar, V. (1992). Activation of b lymphocytes by nk cells. Int Immunol, 4(12), 1373–1380.

    CAS  PubMed  Google Scholar 

  • Zanoni, I., Foti, M., Ricciardi-Castagnoli, P., & Granucci, F. (2005). Tlr-dependent activation stimuli associated with th1 responses confer nk cell stimulatory capacity to mouse dendritic cells. J Immunol, 175(1), 286–292.

    CAS  PubMed  Google Scholar 

  • Zeid, N. A., & Muller, H. K. (1993). S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology, 25(4), 338–343.

    CAS  PubMed  Google Scholar 

  • Zou, W. (2005). Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer, 5(4), 263–274.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy and Pharmaceutical Sciences, 3133 Dentistry/Pharmacy Centre, University of Alberta, Edmonton, Alberta, T6G 2N8, Canada

    Samar Hamdy, Aws Alshamsan & John Samuel

Authors
  1. Samar Hamdy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aws Alshamsan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Samuel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Wisconsin, Madison, WI, USA

    Melgardt M. de Villiers  & Glen S. Kwon  & 

  2. Chulalongkorn University, Bangkok, Thailand

    Pornanong Aramwit

Rights and permissions

Reprints and permissions

Copyright information

© 2009 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Hamdy, S., Alshamsan, A., Samuel, J. (2009). Nanotechnology for Cancer Vaccine Delivery. In: de Villiers, M.M., Aramwit, P., Kwon, G.S. (eds) Nanotechnology in Drug Delivery. Biotechnology: Pharmaceutical Aspects, vol X. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77668-2_17

Download citation

Publish with us

Policies and ethics

Societies and partnerships

Search

Navigation